PMID: 9557630Apr 29, 1998Paper

Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants

Journal of Virology
S YerlyL Perrin

Abstract

Sequences of the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) domain were determined by direct sequencing of HIV-1 RNA in successive plasma samples from eight seroconverting patients infected with virus bearing the T215Y/F amino acid substitution associated with zidovudine (ZDV) resistance. At baseline, additional mutations associated with ZDV resistance were detected. Three patients had the M41L amino acid change, which persisted. Two patients had both the D67N and the K70R amino acid substitutions; reversion to the wild type was seen at both positions in one of these patients and at codon 70 in the other one. Reversion to the wild type at codon 215 was observed in only one of eight patients. Unusual amino acids, such as aspartic acid (D) and cysteine (C), appeared at position 215 in four patients during follow-up. These variants isolated by coculturing were sensitive to ZDV. Overgrowth of these variants suggests that they have better fitness than the original T215Y variant. Intraindividual nucleoside substitutions over time were 10 times more frequent in codons associated with ZDV resistance (41, 67, 70, 215, and 219) than in other codons of the RT domain. The predominance of nonsynonymous substituti...Continue Reading

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·P KellamB A Larder
Dec 1, 1988·AIDS Research and Human Retroviruses·O SchwartzL Montagnier
Aug 17, 1995·The New England Journal of Medicine·S Kinloch-De LoësL Mathiesen
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·H MohriD D Ho
Mar 1, 1997·Nature Medicine·A J Brown, D D Richman

❮ Previous
Next ❯

Citations

Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Y SitnitskayaW Borkowsky
Jun 14, 2005·The Journal of Antimicrobial Chemotherapy·J Gerardo García-Lerma
Jul 13, 2000·Reviews in Medical Virology·D PillayD D Richman
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·J G Garcia-LermaW Heneine
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laura RomanoMaurizio Zazzi
Jul 9, 2004·AIDS·Daniela BezemerNicole K T Back
Aug 31, 2002·AIDS Research and Human Retroviruses·Oscar GallegoVincent Soriano
Dec 4, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David PaoPatricia Cane
Feb 17, 2006·Journal of Medical Virology·Elijah PaintsilLouis Alexander
Apr 22, 2016·Journal of Virology·Soo-Yon RheeRobert W Shafer
Apr 30, 2002·Current Opinion in Infectious Diseases·M NijhuisC Boucher
Apr 5, 2002·Clinical Microbiology Reviews·Robert W Shafer
Mar 10, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·C BrionesV Soriano
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·D R Kuritzkes
Jun 9, 2005·Reviews in Medical Virology·Tim van Opijnen, Ben Berkhout
Jun 14, 2003·AIDS Research and Human Retroviruses·Stephen TaylorDeenan Pillay
Mar 9, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Amanda R MarkovitzSusan E Buskin
Dec 13, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Stephen J GangeRuth Greenblatt
Mar 5, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Maria José BuzónJavier Martinez-Picado
Apr 20, 2011·The Journal of Antimicrobial Chemotherapy·Marieke PingenAnnemarie M J Wensing
May 21, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean L MbisaUNKNOWN UK HIV Drug Resistance Database
Mar 24, 2015·PLoS Pathogens·Wan-Lin YangUNKNOWN Swiss HIV Cohort Study (SHCS)
Mar 10, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S DuweC Kücherer
Jun 14, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.